Working... Menu

Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00120536
Recruitment Status : Completed
First Posted : July 18, 2005
Last Update Posted : May 18, 2017
Information provided by (Responsible Party):